Cargando…
Dopamine Transporter Imaging, Current Status of a Potential Biomarker: A Comprehensive Review
A major goal of current clinical research in Parkinson’s disease (PD) is the validation and standardization of biomarkers enabling early diagnosis, predicting outcomes, understanding PD pathophysiology, and demonstrating target engagement in clinical trials. Molecular imaging with specific dopamine-...
Autores principales: | Palermo, Giovanni, Giannoni, Sara, Bellini, Gabriele, Siciliano, Gabriele, Ceravolo, Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8538800/ https://www.ncbi.nlm.nih.gov/pubmed/34681899 http://dx.doi.org/10.3390/ijms222011234 |
Ejemplares similares
-
Molecular Imaging of the Dopamine Transporter
por: Palermo, Giovanni, et al.
Publicado: (2019) -
Negative DAT‐SPECT in Old Onset Parkinson's Disease: An Additional Pitfall?
por: Palermo, Giovanni, et al.
Publicado: (2022) -
Fluid Biomarkers in Alzheimer’s Disease and Other Neurodegenerative Disorders: Toward Integrative Diagnostic Frameworks and Tailored Treatments
por: Giampietri, Linda, et al.
Publicado: (2022) -
Dopamine Transporter SPECT Imaging in Corticobasal Syndrome
por: Cilia, Roberto, et al.
Publicado: (2011) -
Positive DAT-SCAN in SPG7: a case report mimicking possible MSA-C
por: Bellini, Gabriele, et al.
Publicado: (2021)